What is CJC-1295 (With DAC)?
A clear, research-focused explanation of CJC-1295 (With DAC): what it is, what category of peptide it belongs to, and how it differs from related research compounds.
CJC-1295 (With DAC) at a glance
CJC-1295 (With DAC) is a composition-category research peptide. A long-acting GHRH analogue with Drug Affinity Complex for sustained growth hormone elevation due to extended half-life.
It is sold in the UK for laboratory and in-vitro research use only and is not a medicine, supplement, or product intended for human consumption.
Why researchers study CJC-1295 (With DAC)
CJC-1295 (With DAC) sits within the broader field of composition research. Scientists are typically interested in its mechanism of action, its purity profile, and how it compares with related compounds in the same family. The research literature on CJC-1295 (With DAC) has grown substantially over the last decade as HPLC methods and analytical standards have improved.
At Peptify UK, CJC-1295 (With DAC) is supplied exclusively for this kind of laboratory work — never for therapeutic claims or human-use contexts.
Key facts
Why choose CJC-1295 with DAC? — The DAC modification extends the half-life significantly, allowing for less frequent dosing in research protocols while maintaining sustained GH elevation.
Every research peptide sold by Peptify UK is independently third-party tested using
HPLC (high-performance liquid chromatography) and mass spectrometry to confirm 99%+
purity and correct identity. A batch-specific Certificate of Analysis is published on
every product page and downloadable directly. Peptify is a UK-based research peptide
supplier; Royal Mail Tracked delivery on every order.
Buy CJC-1295 (With DAC) for research
99%+ HPLC-verified CJC-1295 (With DAC) in stock. Every vial ships from the UK with a batch-specific Certificate of Analysis. Same-day dispatch on orders before 1pm.
Frequently asked questions
Why choose CJC-1295 with DAC?
The DAC modification extends the half-life significantly, allowing for less frequent dosing in research protocols while maintaining sustained GH elevation.